Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Am Chem Soc ; 137(33): 10464-7, 2015 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-26261872

RESUMO

Artificial ligands of streptavidin (ALiS) with association constants of ∼10(6) M(-1) were discovered by high-throughput screening of our chemical library, and their binding characteristics, including X-ray crystal structure of the streptavidin complex, were determined. Unlike biotin and its derivatives, ALiS exhibits fast dissociation kinetics and excellent cell permeability. The streptavidin-ALiS system provides a novel, practical compound-dependent methodology for repeated reversible cycling of protein localization between intracellular organella.


Assuntos
Espaço Intracelular/metabolismo , Estreptavidina/metabolismo , Avaliação Pré-Clínica de Medicamentos , Cinética , Ligantes , Modelos Moleculares , Permeabilidade , Conformação Proteica , Transporte Proteico , Estreptavidina/química
2.
Int J Pharm ; 582: 119339, 2020 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-32305366

RESUMO

The objective of the present study was to investigate the effect of molecular weight differences of poly (lactic-co-glycolic acid) (PLGA) on the in vitro release profile of risperidone microspheres. Four different PLGA molecular weights were investigated and all the microsphere formulations were prepared using the same manufacturing process. Physicochemical properties (particle size, drug loading, morphology and molecular weight) as well as in vitro degradation profiles of the prepared microspheres were investigated in addition to in vitro release testing. The in vitro release tests were performed using a previously developed flow through cell (USP apparatus 4) method. The particle size of the four prepared microsphere formulations varied, however there were no significant differences in the drug loading. Interestingly, the in vitro release profiles did not follow the molecular weight of the polymers used. Instead, the drug release appeared to be dependent on the glass transition temperature of the polymers as well as the porosity of the prepared formulations. The catalytic effect of risperidone (an amine drug) on PLGA during manufacturing and release testing, minimized the differences in the molecular weights of the four formulations, explaining the independence of the release profiles on PLGA molecular weight.


Assuntos
Portadores de Fármacos , Copolímero de Ácido Poliláctico e Ácido Poliglicólico/química , Risperidona/química , Difusão , Composição de Medicamentos , Liberação Controlada de Fármacos , Estabilidade de Medicamentos , Cinética , Microesferas , Peso Molecular , Temperatura de Transição , Vitrificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA